Article From: "Don Seiffert"   Read full article

Sage Therapeutics, one of Cambridge’s largest biotech firms, today reported that its pill to treat postpartum depression appears to have succeeded in a late-stage trial.

In a study of 151 women suffering from the condition, those who were given oral medication developed by Cambridge-based Sage, called SAGE 217, showed fewer symptoms of depression than those given a placebo. The drug also appeared to cause no significant side effects.

“These are strong and consistent data demonstrating a rapid,…